Relationship between Duration of Illness and Plasma Concentrations of Antipsychotics in Psychotic Patients

Curry SH Marshall JHL Davis DM Janowsky DS . Chlorpromazine plasma levels and effects. Arch Gen Psychiatry 1970; 22: 289–96.

Smith RC Crayton J Dekirmenjian H Davis JM . Blood levels of neuroleptic drugs in nonresponding chronic schizophrenic patients. Arch Gen Psychiatry 1979; 36: 579–84.

Santos JL Cabranes JA Vazquez C Fuentenebro F Almoguera I Ramos JA . Clinical response and plasma haloperidol levels in chronic and subchronic schizophrenia. Biol Psychiatry 1989; 26: 381–8.

Kim DY Hollister LE . Drug-refractory chronic schizophrenics: Doses and plasma concentrations of thiothixene. J Clin Psychopharmacol 1984; 4: 32–5.

Bergling R Mjorndal T Oreland L Rapp W Woid S . Plasma levels and clinical effects of thioridazine and thiothixene. J Clin Pharmacol 1975; 15: 178–86.

Sakalis G Curry SH Mould GP Lader MH . Physiologic and clinical effects of chlorpromazine and their relationship to plasma level. Clin Pharmacol Ther 1972; 13: 931–46.

Penis C . Indications for long-term pharmacological treatment of schizophrenic syndromes. Pharmakopsychiatrie 1976; 9: 149–58.

Forsman A Ohman R . Applied pharmacokinetics of haloperidol in man. Curr Ther Res 1977; 21: 396–411.

Hudgins R Sramek J Costa J . Low chlorpromazine plasma levels in chronic patients. Fifth Congress Latin-American Biological Psychiatry, April 15–20, 1986; Pueblo, Mexico.

Jann MW Saklad SR Ereshefsky L Richards AL Harrington CA Davis CM . Effects of smoking on haloperidol and reduced haloperidol plasma concentrations and haloperidol clearance. Psychopharmacology 1986; 90: 468–70.

Ereshefsky L Davis CM Harrington CA Jann MW Browning JL Saklad SR . Haloperidol and reduced haloperidol plasma levels in selected schizophrenic patients. J Clin Psychopharmacol 1984; 4: 138–42.